DAVITA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 134.4 USD | -5.48% |
|
+0.70% | +28.34% |
| 05:50pm | UBS Adjusts Price Target on DaVita to $169 From $145, Maintains Buy Rating | MT |
| 04:46pm | Deutsche Bank Adjusts Price Target on DaVita to $145 From $135 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
DaVita Inc. specializes in providing dialysis services. Net sales break down by activity as follows:
- supply of dialysis services (95.3%): hemodialysis and peritoneal dialysis services for patients suffering from chronic renal failure. At the end of 2023, services are insured through 2,675 dialysis centers serving nearly 200,800 patients in the United States, and through 367 dialysis centers serving nearly 49,400 patients abroad;
- other (4.7%).
Calendar
2024-06-06
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
142.2
USD
Average target price
139.9
USD
Spread / Average Target
-1.62%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +28.34% | 12.47B | |
| +13.70% | 81.68B | |
| -29.20% | 69.23B | |
| +9.72% | 29.08B | |
| -11.43% | 16.88B | |
| -0.43% | 16.85B | |
| -0.31% | 15.15B | |
| +3.42% | 12.62B | |
| -30.70% | 11.89B | |
| -6.75% | 11.68B |
- Stock Market
- Equities
- DVA Stock
- News DaVita Inc.
- Insider Trends: DaVita Insider Converts Option/Derivative Security to Acquire Stock, Makes Tax Sale, Selling Trend Intact
